IO 125
Alternative Names: IO-125Latest Information Update: 28 Oct 2019
At a glance
- Originator Invictus Oncology
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Triple negative breast cancer
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for preclinical development in Triple negative Breast-cancer in India
- 16 Apr 2016 Pharmacodynamics data from a preclinical trial in Breast cancer presented at the 107th Annual Meeting of the American Association for Cancer Research (AACR-2016)
- 23 Sep 2015 Preclinical trials in Triple negative Breast cancer in India (unspecified route)